Dicle İSKENDER, Mehmet OBUT, Ayşe KELEŞ, Ozgur ARAT, Özge YÜCEL ÇELİK, Dilara SARIKAYA, Mehmet KAYA, Mehmet Sinan DAL, Cantekin İSKENDER

Diagnostic performance of hematological indices in early and late preeclampsia

To evaluate diagnostic performance of Neutrophil/lymphocyte ratio (NLR), Platelet to lymphocyte ratio (PLR) and platelecrit in the first and third trimester in preeclampsia. This was a single center case control study conducted between January 2015 and January 2021. Patients diagnosed with preeclampsia were assigned as study population. The preeclamptic patients were assigned into two groups based on gestational weeks at diagnosis. Patients diagnosed before 34th gestational weeks were categorized as early preeclampsia and whereas patients diagnosed after 34th gestational weeks as late preeclampsia. Receiver operating characteristics curve was used to assess diagnostic value of first and third trimester NLR, PLR and platelecrit in preeclampsia. Detection rate of each variable was assessed for a 10% false positive rate. NLR in the first trimester have highest sensitivity of 30 % at a 90 % specificity to detect early preeclampsia. The area under curve (AUC) for NLR was 0.742 respectively. The best cut off for 1st trimester NLR was 4.98. PLR and platelecrit yielded low diagnostic performance. NLR in the first trimester has a moderate predictive performance for early preeclampsia. PLR was not different in preeclamptic cases and controls and platelecrit yielded a low diagnostic performance for preeclampsia.

PDF

___

1. Sahai K, Saraswathy S, Yadav TP, et al. Pre-eclampsia: Molecular events to biomarkers. Med J Armed Forces India. 2017;73:167-74

2. Wright D, Wright A, Nicolaides KH. The competing risk approach for prediction of preeclampsia. Am J Obstet Gynecol. 2020;223:12-23.e7.

3. Gogoi P, Sinha P, Gupta B, Firmal P, et al. Neutrophil-to-lymphocyte ratio and platelet indices in pre-eclampsia. Int J Gynaecol Obstet. 2019;144:16- 20.

4. Belovic DK, Plešinac S, Dotlić J, et al. Biochemical Markers for Prediction of Hypertensive Disorders of Pregnancy. J Med Biochem. 2019;38:71-82.

5. ACOG Committee Opinion No. 743: Low-Dose Aspirin Use During Pregnancy. Obstet Gynecol. 2018;132:e44-e52.

6. Mirkovic L, Tulic I, Stankovic S, et al. Prediction of adverse maternal outcomes of early severe preeclampsia. Pregnancy Hypertens. 2020; 22:144-50.

7. Allen R, Aquilina J. Prospective observational study to determine the accuracy of first-trimester serum biomarkers and uterine artery Dopplers in combination with maternal characteristics and arteriography for the prediction of women at risk of preeclampsia and other adverse pregnancy outcomes. J Matern Fetal Neonatal Med. 2018;31:2789-806.

8. Obut M, Oğlak SC. Expression of CD44 and IL-10 in normotensive and preeclamptic placental tissue. Ginekol Pol. 2020;9:334-41.

9. Laresgoiti-Servitje E. A leading role for the immune system in the pathophysiology of preeclampsia. J Leukoc Biol. 2013;94:247-57.

10. Yavuzcan A, Cağlar M, Ustün Y, et al. Mean platelet volume, neutrophillymphocyte ratio and platelet-lymphocyte ratio in severe preeclampsia. Ginekol Pol. 2014;85:197-203.

11. Kirbas A, Ersoy AO, Daglar K, et al. Prediction of Preeclampsia by First Trimester Combined Test and Simple Complete Blood Count Parameters. J Clin Diagn Res. 2015;9:QC20-3.

12. Yücel B, Ustun B. Neutrophil to lymphocyte ratio, platelet to lymphocyte ratio, mean platelet volume, red cell distribution width and plateletcrit in preeclampsia. Pregnancy Hypertens. 2017;7:29-32.

13. Çintesun E, Incesu Çintesun FN, Ezveci H, et al. Systemic inflammatory response markers in preeclampsia. J Lab Physicians. 2018;10:316-9.

14. Kang Q, Li W, Yu N, Fan L, et al. Predictive role of neutrophil-tolymphocyte ratio in preeclampsia: A meta-analysis including 3982 patients. Pregnancy Hypertens. 2020;20:111-8.

15. Gezer C, Ekin A, Ertas IE, et al. High first-trimester neutrophil-tolymphocyte and platelet-to-lymphocyte ratios are indicators for early diagnosis of preeclampsia. Ginekol Pol. 2016;87:431-5.

16. Panwar M, Kumari A, Hp A, et al. Raised neutrophil lymphocyte ratio and serum beta hCG level in early second trimester of pregnancy as predictors for development and severity of preeclampsia. Drug Discov Ther. 2019;13:34-7.

17. Mannaerts D, Heyvaert S, De Cordt C, et al. Are neutrophil/lymphocyte ratio (NLR), platelet/lymphocyte ratio (PLR), and/or mean platelet volume (MPV) clinically useful as predictive parameters for preeclampsia? J Matern Fetal Neonatal Med. 2019;32:1412-9.

18. Oylumlu M, Ozler A, Yildiz A, et al. New inflammatory markers in preeclampsia: echocardiographic epicardial fat thickness and neutrophil to lymphocyte ratio. Clin Exp Hypertens. 2014;36:503-7.

19. Kim MA, Han GH, Kwon JY, Kim YH. Clinical significance of plateletto- lymphocyte ratio in women with preeclampsia. Am J Reprod Immunol. 2018;80:e12973.

20. Karateke A, Kurt RK, Baloglu A. Relation of platelet distribution width (PDW) and platelet crit (PCT) to preeclampsia. Ginekol Pol. 2015;86:372-5.

21. Freitas GL, Alpoim PN, Komatsuzaki F, et al. Preeclampsia: are platelet count and indices useful for its prognostic? Hematology. 2013;18:360–4.